化工社化工社 化学情報印刷レポート · 研究参考用
4,5-Dichloro-2-methyl-4-isothiazolin-3-one
4,5-DICHLORO-2-METHYLISOTHIAZOLINONE · 4,5-Dichloro-2-Methylisothiazol-3-one · 4,5-dichloro-2-methyl-1,2-thiazol-3-one · 4,5-Dichloro-2-methylisothiazol-3(2H)-one · 4,5-Dichloro-2-methyl-3(2H)-isothiazolone · 4,5-dichloro-2-methyl-4-isothiazolin-3-one · 3(2H)-Isothiazolone, 4,5-dichloro-2-methyl-

識別子と物理属性
| CAS No. | 26542-23-4 |
|---|---|
| 分子式 | C4H3Cl2NOS |
| 平均分子量 | 184.04 g/mol |
| 単同位体質量 | 182.93124008 g/mol |
| SMILES | Cn1sc(Cl)c(Cl)c1=O |
| InChIKey | CVZDIUZSWUDGOP-UHFFFAOYSA-N |
| PubChem CID | 147017 |
| EC No. | 998-506-8 |
| DTXSID | DTXSID50181116 |
化学・物理的性質
| XLogP | 1.7 |
|---|---|
| 極性表面積 | 45.6 |
| 水素結合供与体数 | 0 |
| 水素結合受容体数 | 2 |
| 回転可能結合数 | 0 |
| 重原子数 | 9 |
| 形式電荷 | 0 |
| 複雑度 | 191 |
| 融点 | 116 °C |
| 沸点 | 199.1±50.0 °C(Predicted) |
| 密度 | 1.66±0.1 g/cm3(Predicted) |
| 貯蔵条件 | -20°C Freezer |
| 溶解度 | クロロホルム(微量)、酢酸エチル(微量)、メタノール(微量) |
| 外観・状態 | 個体 |
| pKa(酸解離定数) | -6.08±0.60(Predicted) |
| 色 | ホワイトからオフホワイト |
安全性と法規制
| GHS 分類 | DangerH301+H311+H331 (100%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oralacute toxicity, dermalacute toxicity, inhalation]P260, P261, P262, P264, P264+P265, P270, P271, P272, P273, P280, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P333+P317, P361+P364, P362+P364, P363, P391, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 37 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 規制情報 | Chemical: 3(2H)-Isothiazolone, 4,5-dichloro-2-methyl- |
| その他の安全情報 | IMAP assessments - 3(2H)-Isothiazolone, 4,5-dichloro-2-methyl-: Human health tier I assessment |
| Hazard Classes and Categories | Acute Tox. 3 (100%) |
| 輸送番号(UN) | 2922 |
| 危険等級 | 8 |
| 包装等級 | III |
用途
使用
4,5-Dichloro-2-methylisothiazol-3-one is an methylisothiazolinone derivative and a potential antimicrobial agent for the inhibition of PCAF activity.